Outset Medical Inc

For the period ended Jun 30, 2024. Filed Aug 8, 2024.

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Jun 30, 2024 · Filed Aug 8, 2024

OM$4.23+3.2%Stored close · as of Nov 6, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Condensed Statements of Operations

(in thousands, except per share amounts)

Three Months Ended · Six Months Ended
	June 30,		June 30,
	2024	2023	2024	2023
Revenue:
Product revenue	$19,238	$29,330	$39,666	$57,109
Service and other revenue	8,150	6,710	15,890	12,398
Total revenue	27,388	36,040	55,556	69,507
Cost of revenue:
Cost of product revenue	10,567	22,212	23,148	43,029
Cost of service and other revenue	7,039	6,125	14,411	12,347
Total cost of revenue	17,606	28,337	37,559	55,376
Gross profit	9,782	7,703	17,997	14,131
Operating expenses:
Research and development	9,734	14,906	22,369	28,699
Sales and marketing	18,128	24,985	39,176	49,318
General and administrative	12,684	11,290	24,128	23,077
Total operating expenses	40,546	51,181	85,673	101,094
Loss from operations	(30,764)	(43,478)	(67,676)	(86,963)
Interest income and other income, net	2,471	2,668	5,569	5,316
Interest expense	(6,010)	(3,103)	(11,978)	(6,045)
Loss before provision for income taxes	(34,303)	(43,913)	(74,085)	(87,692)
Provision for income taxes	151	133	313	325
Net loss	$(34,454)	$(44,046)	$(74,398)	$(88,017)
Net loss per share, basic and diluted	$(0.66)	$(0.90)	$(1.45)	$(1.79)
Shares used in computing net loss per share, basic and diluted	51,880	48,951	51,391	49,085

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.